Norway
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 4.74 M
|
Dec. 31, 2023 | USD 5.15 | 1.58% |
|
Norway |
|
2 |
USD 1.52 M
|
Dec. 31, 2023 | USD 4.11 | 5.18% |
|
Norway |
|
3 |
USD 213.92 K
|
Dec. 31, 2023 | USD 2.23 | 3.92% |
|
Norway |
|
4 |
USD -3.53 M
|
Dec. 31, 2023 | USD 1.16 | 3.36% |
|
Norway |
|
5 |
USD -6.29 M
|
Dec. 31, 2023 | USD 0.22 | -1.39% |
|
Norway |
|
6 |
USD -18.64 M
|
Dec. 31, 2023 | USD 0.19 | 1.62% |
|
Norway |
|
7 |
USD -22.10 M
|
Dec. 31, 2023 | USD 0.71 | -1.42% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Operating Cash Flow is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 4.74 M.
The Pharmaceuticals company in Norway with the lowest Operating Cash Flow is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at USD -22.10 M.
The top 10 Pharmaceuticals companies in Norway by Operating Cash Flow are Photocure ASA, Gentian Diagnostics ASA, Navamedic ASA, Lifecare AS, Thor Medical ASA, Ultimovacs ASA and BerGenBio ASA.
The bottom 10 Pharmaceuticals companies in Norway by Operating Cash Flow are BerGenBio ASA, Ultimovacs ASA, Thor Medical ASA, Lifecare AS, Navamedic ASA, Gentian Diagnostics ASA and Photocure ASA.